Sangamo Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan '26 Jan 16, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	152	206	87	481	961	1,804
Market Cap Growth	-32.01%	135.82%	-81.90%	-49.88%	-46.76%	108.67%
Enterprise Value	148	194	-1	191	540	1,270
Last Close Price	0.38	2.47	0.50	2.85	6.91	14.20
PS Ratio	5.41	3.68	0.55	4.62	9.87	18.68
PB Ratio	28.50	9.35	1.16	1.75	2.91	4.44
P/TBV Ratio	28.50	9.35	1.16	2.49	3.88	5.56
P/FCF Ratio	-	-	-	-	-	14.23
P/OCF Ratio	-	-	-	-	-	12.99
EV/Sales Ratio	5.35	3.48	-	1.83	5.54	13.15
EV/FCF Ratio	-2.28	-	-	-	-	10.01
Debt / Equity Ratio	4.07	1.34	0.46	0.15	0.13	0.09
Debt / FCF Ratio	-	-	-	-	-	0.27
Asset Turnover	0.33	0.43	0.48	0.17	0.13	0.15
Quick Ratio	0.69	1.02	1.78	2.53	2.99	4.51
Current Ratio	0.88	1.13	1.98	2.69	3.12	4.60
Return on Equity (ROE)	-480.02%	-185.39%	-136.47%	-57.37%	-40.86%	-26.05%
Return on Assets (ROA)	-68.11%	-46.05%	-19.63%	-19.59%	-13.80%	-10.27%
Return on Capital Employed (ROCE)	-282.80%	-176.20%	-97.20%	-44.60%	-30.90%	-16.30%
Earnings Yield	-61.20%	-46.02%	-267.59%	-37.37%	-16.32%	-5.48%
FCF Yield	-42.93%	-31.67%	-255.31%	-47.38%	-23.48%	7.03%
Buyback Yield / Dilution	-28.22%	-15.62%	-13.02%	-6.76%	-7.53%	-19.92%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.